Broocks, Gabriel http://orcid.org/0000-0002-7575-9850
Kemmling, Andre
Aberle, Jens
Kniep, Helge
Bechstein, Matthias
Flottmann, Fabian
Leischner, Hannes
Faizy, Tobias D.
Nawabi, Jawed
Schön, Gerhard
Sporns, Peter
Thomalla, Götz
Fiehler, Jens
Hanning, Uta
Article History
Received: 15 September 2019
Revised: 20 October 2019
Accepted: 21 October 2019
First Online: 30 October 2019
Compliance with ethical standards
:
: Prof. Fiehler: Research support: German Ministry of Science and Education (BMBF and BMWi), German Research Foundation (DFG), European Union (EU), Hamburgische Investitions- und Förderbank (IFB), Medtronic, Microvention, Philips, Stryker, Consultant for: Acandis, Boehringer Ingelheim, Cerenovus, Covidien, Evasc Neurovascular, MD Clinicals, Medtronic, Medina, Microvention, Penumbra, Route92, Stryker, Transverse Medical. Prof. Thomalla: Consultant for Acandis, Bayer Healthcare, Boehringer Ingelheim, BristolMyersSquibb/Pfizer, Covidien, Glaxo Smith Kline; lead investigator of the WAKE-UP study; Principal Investigator of the THRILL study; Grants by the European Union (Grant No. 278276 und 634809) and Deutsche Forschungsgemeinschaft (SFB 936, Projekt C2). All author authors report no disclosures.
: Anonymized data were recorded in accordance with ethical review board approval and institutional review board waived informed consent. The data that support the findings of this study are available from the corresponding author upon reasonable request.